- Lexicon Pharmaceuticals (NASDAQ:LXRX): Q4 EPS of -$0.31 beats by $0.21.
- Revenue of $23.04M (-81.9% Y/Y) beats by $7.4M.
- Press Release
- Update: Shares are up 5% premarket on light volume.
Lexicon Pharmaceuticals beats by $0.21, beats on revenue
Recommended For You
About LXRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
LXRX | - | - |
Lexicon Pharmaceuticals, Inc. |